Abstract
Background A brief neuroscience-informed psychoeducation program (neuroscience-informed psychoeducation for recovery, NIPER) was developed to promote awareness (metacognition) in the main cognitive domains affected by drug and alcohol use to increase willingness to invest time and effort in the brain and cognition recovery process. The primary aim of this study was to determine the feasibility and acceptability of the NIPER program and its potential effectiveness in terms of increasing metacognition, psychological wellbeing and willingness for the brain and cognition recovery programs among people with substance use disorders (SUDs).
Methodology 56 individuals with SUDs recruited from four outpatient treatment centres in Tehran, Iran and attended four 90-min sessions delivered weekly adjunct to their treatment as usual. The effectiveness was measured in terms of metacognition, and psychological wellbeing at baseline and at the end of the program. Rate of adherence and participation as well as willingness to continue with brain and cognition recovery programs were measured as feasibility outcomes.
Results A total of 51 participants completed the study. Compared to the baseline assessments, participants reported significantly higher problems in dimensions of attention, memory, inhibitory control, decision making, motor/speech, interocpetion and insight, as well as higher level of psychological wellbeing (t=4.66. p<0.001). In terms of feasibility outcomes, the adherence and participation rates were found above 85%. The majority of participants expressed their high willingness to continue the brain and cognition recovery programs (86.2%) and introduce NIPER to their peers (98%).
Conclusion Taking into account the results in terms of feasibility and preliminary effectiveness of NIPER in clinical context of addiction treatment, we consider NIPER as a potentially beneficial interventions to be offered to people with SUD to increase their awareness and engage them to the brain and cognition recovery process. The clinical efficacy of the intervention should be tested in future randomized clinical trials.
Competing Interest Statement
NIPER is designed by HE, TR, Brad Collins and Martin Paulus. HE and TR receive royalty from the publication of the posters and booklets designed based on the NIPER materials.
Funding Statement
This study was supported by Tehran University of Medical Sciences Deputy of Research under Project No. 98-02-49-43260.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study has been approved by the Tehran University of Medical Sciences research ethics committee (IR.TUMS.VCR.REC.1398.771).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The study is a feasibility study.